Ly; Tai Wei
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ly; Tai Wei.The latest application filed is for "antiviral agents".
Company Profile
3.36.36
- Ly; Tai Wei - San Diego CA
- Ly; Tai-Wei - Taipei TW
- LY; Tai-Wei - Taipei City TW
Patent Activity
| Patent | Date |
|---|---|
| Fms-like tyrosine kinase inhibitors Grant 11,332,476 - Chen , et al. May 17, 2 | 2022-05-17 |
| Ammonium salts of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one and uses thereof Grant 11,304,930 - Cha , et al. April 19, 2 | 2022-04-19 |
| Antiviral Agents App 20220098169 - Ly; Tai-Wei ; et al. | 2022-03-31 |
| Ammonium Salts Of 3-(3,5-dibromo-4-hydroxybenzyliden)-5-indo-1,3-dihydroindol-2-one And Uses Thereof App 20210283103 - CHA; Tai-Lung ; et al. | 2021-09-16 |
| Fms-like Tyrosine Kinase Inhibitors App 20200131194 - Chen; Jung-Hsiang ; et al. | 2020-04-30 |
| 3,5-diaminopyrazole kinase inhibitors Grant 9,730,914 - Ly August 15, 2 | 2017-08-15 |
| Isotopically enriched arylsulfonamide CCR3 antagonists Grant 9,637,460 - Ly , et al. May 2, 2 | 2017-05-02 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20170087131 - LY; Tai Wei | 2017-03-30 |
| Pharmaceutically Acceptable Salts Of 3,5-diaminopyrazole Kinase Inhibitors App 20170079954 - LY; Tai Wei ; et al. | 2017-03-23 |
| 3,5-diaminopyrazole kinase inhibitors Grant 9,546,163 - Ly January 17, 2 | 2017-01-17 |
| Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors Grant 9,540,351 - Ly , et al. January 10, 2 | 2017-01-10 |
| 3,5-diaminopyrazole kinase inhibitors Grant 9,382,237 - Raaum , et al. July 5, 2 | 2016-07-05 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20160176857 - LY; Tai Wei | 2016-06-23 |
| 3,5-diaminopyrazole kinase inhibitors Grant 9,365,556 - Raaum , et al. June 14, 2 | 2016-06-14 |
| 3,5-diaminopyrazole kinase inhibitors Grant 9,346,792 - Raaum , et al. May 24, 2 | 2016-05-24 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20160031841 - Ly; Tai Wei ; et al. | 2016-02-04 |
| 2,5-disubstituted arylsulfonamide CCR3 antagonists Grant 9,187,425 - Ly , et al. November 17, 2 | 2015-11-17 |
| Isotopically Enriched Arylsulfonamide Ccr3 Antagonists App 20150315158 - Ly; Tai Wei ; et al. | 2015-11-05 |
| Isotopically enriched arylsulfonamide CCR3 antagonists Grant 9,156,799 - Ly , et al. October 13, 2 | 2015-10-13 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20150105389 - RAAUM; Erik Dean ; et al. | 2015-04-16 |
| Isotopically enriched arylsulfonamide CCR3 antagonists Grant 8,999,995 - Ly , et al. April 7, 2 | 2015-04-07 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20150080398 - RAAUM; Erik Dean ; et al. | 2015-03-19 |
| Pharmaceutically Acceptable Salts Of 3,5-diaminopyrazole Kinase Inhibitors App 20150080397 - LY; Tai Wei ; et al. | 2015-03-19 |
| 3,5-diaminopyrazole kinase inhibitors Grant 8,916,555 - Raaum , et al. December 23, 2 | 2014-12-23 |
| Arylsulfonamide Ccr3 Antagonists App 20140221428 - LY; Tai Wei ; et al. | 2014-08-07 |
| Arylsulfonamide CCR3 antagonists Grant 8,741,894 - Ly , et al. June 3, 2 | 2014-06-03 |
| Isotopically Enriched Arylsulfonamide Ccr3 Antagonists App 20140073649 - Ly; Tai Wei ; et al. | 2014-03-13 |
| 2,5-disubstituted arylsulfonamide CCR3 antagonists Grant 8,669,247 - Ly , et al. March 11, 2 | 2014-03-11 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20140066446 - Ly; Tai Wei ; et al. | 2014-03-06 |
| Arylsulfonamide CCR3 antagonists Grant 8,658,642 - Ly , et al. February 25, 2 | 2014-02-25 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20130303492 - Raaum; Erik Dean ; et al. | 2013-11-14 |
| 2,5-disubstituted arylsulfonamide CCR3 antagonists Grant 8,563,544 - Ly , et al. October 22, 2 | 2013-10-22 |
| 3,5-diaminopyrazole Kinase Inhibitors App 20130274227 - RAAUM; Erik Dean ; et al. | 2013-10-17 |
| Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists Grant 8,541,419 - Ly September 24, 2 | 2013-09-24 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20130225565 - LY; Tai Wei ; et al. | 2013-08-29 |
| Arylsulfonamide Ccr3 Antagonists App 20130217687 - LY; Tai Wei ; et al. | 2013-08-22 |
| Particulates of a CRTH2 antagonist Grant 8,507,005 - Ly , et al. August 13, 2 | 2013-08-13 |
| Arylsulfonamide CCR3 antagonists Grant 8,420,639 - Ly , et al. April 16, 2 | 2013-04-16 |
| 2,5-disubstituted arylsulfonamide CCR3 antagonists Grant 8,399,456 - Ly , et al. March 19, 2 | 2013-03-19 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20130065889 - LY; Tai Wei ; et al. | 2013-03-14 |
| Alkylthio pyrimidines as CRTH2 antagonists Grant 8,324,229 - Ly , et al. December 4, 2 | 2012-12-04 |
| 2,5-disubstituted arylsulfonamide CCR3 antagonists Grant 8,318,747 - Ly , et al. November 27, 2 | 2012-11-27 |
| 2-S-benzyl substituted pyrimidines as CRTH2 antagonists Grant 8,314,116 - Ly , et al. November 20, 2 | 2012-11-20 |
| Amine salts of a CRTH2 antagonist Grant 8,278,310 - Ly October 2, 2 | 2012-10-02 |
| Salts Of Arylsulfonamide Ccr3 Antagonists App 20120088769 - LY; Tai Wei | 2012-04-12 |
| Arylsulfonamide Ccr3 Antagonists App 20110230487 - LY; Tai Wei ; et al. | 2011-09-22 |
| Isotopically Enriched Arylsulfonamide Ccr3 Antagonists App 20110218207 - Ly; Tai Wei ; et al. | 2011-09-08 |
| Isotopically Enriched Pyrimidin-5-yl Acetic Acid Derivatives As Crth2 Antagonists App 20110172250 - Ly; Tai Wei | 2011-07-14 |
| Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 Grant 7,960,393 - Ly , et al. June 14, 2 | 2011-06-14 |
| Particulates Of A Crth2 Antagonist App 20110052701 - Ly; Tai Wei ; et al. | 2011-03-03 |
| Amine Salts Of A Crth2 Antagonist App 20110034482 - Ly; Tai Wei | 2011-02-10 |
| Pyrimidine Derivatives Useful For The Treatment Of Diseases Mediated By Crth2 App 20100322980 - Ly; Tai-wei ; et al. | 2010-12-23 |
| Alkylthio Pyrimidines As CRTH2 Antagonists App 20100298361 - Ly; Tai Wei | 2010-11-25 |
| Arylsulfonamide Ccr3 Antagonists App 20100273795 - Ly; Tai Wei ; et al. | 2010-10-28 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20100273782 - Ly; Tai Wei ; et al. | 2010-10-28 |
| 2,5-disubstituted Arylsulfonamide Ccr3 Antagonists App 20100273785 - Ly; Tai Wei ; et al. | 2010-10-28 |
| Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 Grant 7,812,160 - Ly , et al. October 12, 2 | 2010-10-12 |
| 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists App 20100240685 - Ly; Tai Wei ; et al. | 2010-09-23 |
| Imidazo[1,2-C]pyrimidinylacetic acid derivatives Grant 7,750,014 - Ly , et al. July 6, 2 | 2010-07-06 |
| Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives App 20090012102 - Ly; Tai-wei ; et al. | 2009-01-08 |
| Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 App 20070129355 - Ly; Tai-wei ; et al. | 2007-06-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 